Publication:
Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference.

dc.contributor.authorVogler, Sabine
dc.contributor.authorZimmermann, Nina
dc.contributor.authorBabar, Zaheer-Ud-Din
dc.contributor.authorBusse, Reinhard
dc.contributor.authorEspin-Balbino, Jaime
dc.contributor.authorMantel-Teeuwisse, Aukje K
dc.contributor.authorPanteli, Dimitra
dc.contributor.authorSuleman, Fatima
dc.contributor.authorWirtz, Veronika J
dc.date.accessioned2023-02-09T10:40:20Z
dc.date.available2023-02-09T10:40:20Z
dc.date.issued2021-01-25
dc.description.abstractThe 4th PPRI Conference, held in Vienna in October 2019, addressed issues related to equitable and affordable access to medicines. A multi-stakeholder audience from around the globe discussed solutions and best practice models for current challenges such as high-priced medicines, limitations of current pricing and reimbursement policies and tight budgets for health technologies. A multi-faceted approach (so-called balance, evidence, collaboration and transparency/BECT strategy) was also discussed. This includes an improved balance of different interests and policy areas, generation of relevant evidence, collaboration between countries and stakeholders, and transparency, and was considered as the most promising pathway for the future.
dc.description.versionSi
dc.identifier.citationVogler S, Zimmermann N, Babar ZU, Busse R, Espin J, Mantel-Teeuwisse AK, et al. Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference. J Pharm Policy Pract. 2021 Jan 25;14(1):18.
dc.identifier.doi10.1186/s40545-021-00300-3
dc.identifier.issn2052-3211
dc.identifier.pmcPMC7829652
dc.identifier.pmid33494798
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829652/pdf
dc.identifier.unpaywallURLhttps://doi.org/10.1186/s40545-021-00300-3
dc.identifier.urihttp://hdl.handle.net/10668/17038
dc.issue.number1
dc.journal.titleJournal of pharmaceutical policy and practice
dc.journal.titleabbreviationJ Pharm Policy Pract
dc.language.isoen
dc.organizationEscuela Andaluza de Salud Pública-EASP
dc.page.number18
dc.publisherBioMed Central
dc.pubmedtypeLetter
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectAccess to medicines
dc.subjectAffordability
dc.subjectCollaboration
dc.subjectDebate
dc.subjectMedicine prices
dc.subjectPolicy options
dc.subjectPricing policies
dc.subjectReimbursement
dc.subject.decsAccesibilidad a los Servicios de Salud
dc.subject.decsPrecio de Medicamento
dc.subject.decsMecanismo de Reembolso
dc.subject.decsEconomía Farmacéutica
dc.subject.meshHealth Services Accessibility
dc.subject.meshMedicine prices
dc.subject.meshReimbursement Mechanisms
dc.subject.meshEconomics, Pharmaceutical
dc.titleAddressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number14
dspace.entity.typePublication
person.affiliation.name[Espin-Balbino,J] Andalusian School of Public Health (EASP), Granada, Spain.

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Vogler_Addressing.pdf
Size:
1.5 MB
Format:
Adobe Portable Document Format